174 related articles for article (PubMed ID: 12787416)
1. Renal cell carcinoma as a cause of end-stage renal disease in the United States: patient characteristics and survival.
Stiles KP; Moffatt MJ; Agodoa LY; Swanson SJ; Abbott KC
Kidney Int; 2003 Jul; 64(1):247-53. PubMed ID: 12787416
[TBL] [Abstract][Full Text] [Related]
2. Partial nephrectomy for the treatment of renal cell carcinoma (RCC) and the risk of end-stage renal disease (ESRD).
Yap SA; Finelli A; Urbach DR; Tomlinson GA; Alibhai SM
BJU Int; 2015 Jun; 115(6):897-906. PubMed ID: 25065448
[TBL] [Abstract][Full Text] [Related]
3. Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
Schmitges J; Trinh QD; Sun M; Hansen J; Bianchi M; Jeldres C; Perrotte P; Dahlem R; Shariat SF; Chun FK; Montorsi F; Menon M; Fisch M; Graefen M; Karakiewicz PI
BJU Int; 2012 Sep; 110(6 Pt B):E183-90. PubMed ID: 22321256
[TBL] [Abstract][Full Text] [Related]
4. Risk of end-stage renal disease after cancer nephrectomy in Taiwan: a nationwide population-based study.
Lin WY; Liang FW; Lu TH
PLoS One; 2015; 10(5):e0126965. PubMed ID: 25993556
[TBL] [Abstract][Full Text] [Related]
5. Renal cell carcinoma in patients with end-stage renal disease has favorable overall prognosis.
Shrewsberry AB; Osunkoya AO; Jiang K; Westby R; Canter D; Pattaras J; Turgeon N; Master VA; Ogan K
Clin Transplant; 2014 Feb; 28(2):211-6. PubMed ID: 24494735
[TBL] [Abstract][Full Text] [Related]
6. Unilateral renal cell carcinoma with coexistent renal disease: a rare cause of end-stage renal disease.
Peces R; Alvarez-Navascués R
Nephrol Dial Transplant; 2001 Feb; 16(2):291-4. PubMed ID: 11158402
[TBL] [Abstract][Full Text] [Related]
7. Increased risk of end-stage renal disease in patients with renal cell carcinoma: a 12-year nationwide follow-up study.
Hung PH; Tsai HB; Hung KY; Muo CH; Chung MC; Chang CH; Chung CJ
Medicine (Baltimore); 2014 Aug; 93(8):e52. PubMed ID: 25121356
[TBL] [Abstract][Full Text] [Related]
8. Scleroderma at end stage renal disease in the United States: patient characteristics and survival.
Abbott KC; Trespalacios FC; Welch PG; Agodoa LY
J Nephrol; 2002; 15(3):236-40. PubMed ID: 12113593
[TBL] [Abstract][Full Text] [Related]
9. Renal cell carcinoma (RCC) in patients with end-stage renal disease exhibits many favourable clinical, pathologic, and outcome features compared with RCC in the general population.
Neuzillet Y; Tillou X; Mathieu R; Long JA; Gigante M; Paparel P; Poissonnier L; Baumert H; Escudier B; Lang H; Rioux-Leclercq N; Bigot P; Bernhard JC; Albiges L; Bastien L; Petit J; Saint F; Bruyere F; Boutin JM; Brichart N; Karam G; Branchereau J; Ferriere JM; Wallerand H; Barbet S; Elkentaoui H; Hubert J; Feuillu B; Theveniaud PE; Villers A; Zini L; Descazeaux A; Roupret M; Barrou B; Fehri K; Lebret T; Tostain J; Terrier JE; Terrier N; Martin L; Dugardin F; Galliot I; Staerman F; Azemar MD; Irani J; Tisserand B; Timsit MO; Sallusto F; Rischmann P; Guy L; Valeri A; Deruelle C; Azzouzi AR; Chautard D; Mejean A; Salomon L; Rigaud J; Pfister C; Soulié M; Kleinclauss F; Badet L; Patard JJ; ;
Eur Urol; 2011 Aug; 60(2):366-73. PubMed ID: 21377780
[TBL] [Abstract][Full Text] [Related]
10. Renal cell carcinoma in patients with end-stage renal disease: relationship between histological type and duration of dialysis.
Nouh MA; Kuroda N; Yamashita M; Hayashida Y; Yano T; Minakuchi J; Taniguchi S; Nomura I; Inui M; Sugimoto M; Kakehi Y
BJU Int; 2010 Mar; 105(5):620-7. PubMed ID: 19747356
[TBL] [Abstract][Full Text] [Related]
11. Post-operative acute kidney injury in patients with renal cell carcinoma is a potent risk factor for new-onset chronic kidney disease after radical nephrectomy.
Cho A; Lee JE; Kwon GY; Huh W; Lee HM; Kim YG; Kim DJ; Oh HY; Choi HY
Nephrol Dial Transplant; 2011 Nov; 26(11):3496-501. PubMed ID: 21406544
[TBL] [Abstract][Full Text] [Related]
12. Outcomes and Management Considerations in Patients on Dialysis Undergoing Laparoscopic Radical Nephrectomy for Renal-Cell Carcinoma.
Keehn A; Maiman R; Agalliu I; Taylor J; Ghavamian R
J Endourol; 2015 Jun; 29(6):691-5. PubMed ID: 25423552
[TBL] [Abstract][Full Text] [Related]
13. Renal cell carcinoma outcomes in end-stage renal disease: A 40-year study from two Japanese institutions.
Ishihara H; Ikeda T; Fukuda H; Yoshida K; Kobayashi H; Iizuka J; Nagashima Y; Kondo T; Takagi T
Int J Urol; 2024 Jan; 31(1):73-81. PubMed ID: 37798866
[TBL] [Abstract][Full Text] [Related]
14. Clinical and pathological outcomes of renal cell carcinoma (RCC) in native kidneys of patients with end-stage renal disease: a long-term comparative retrospective study with RCC diagnosed in the general population.
Breda A; Lucarelli G; Rodriguez-Faba O; Guirado L; Facundo C; Bettocchi C; Gesualdo L; Castellano G; Grandaliano G; Battaglia M; Palou J; Ditonno P; Villavicencio H
World J Urol; 2015 Jan; 33(1):1-7. PubMed ID: 24504760
[TBL] [Abstract][Full Text] [Related]
15. Population-based analysis of factors associated with survival in patients undergoing cytoreductive nephrectomy in the targeted therapy era.
Culp SH; Karam JA; Wood CG
Urol Oncol; 2014 Jul; 32(5):561-8. PubMed ID: 24709415
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.
Hajj P; Ferlicot S; Massoud W; Awad A; Hammoudi Y; Charpentier B; Durrbach A; Droupy S; Benoît G
Urology; 2009 Sep; 74(3):631-4. PubMed ID: 19616833
[TBL] [Abstract][Full Text] [Related]
17. No tumor-free waiting period after treatment of multilocular cystic renal cell carcinoma: a new case and review of the literature.
Tantisattamo E; Elam A; Cobb J; Ellis CL; Bailey JL
Am J Nephrol; 2014; 40(2):151-6. PubMed ID: 25171490
[TBL] [Abstract][Full Text] [Related]
18. Survival after partial and radical nephrectomy for the treatment of stage T1bN0M0 renal cell carcinoma (RCC) in the USA: a propensity scoring approach.
Badalato GM; Kates M; Wisnivesky JP; Choudhury AR; McKiernan JM
BJU Int; 2012 May; 109(10):1457-62. PubMed ID: 21933334
[TBL] [Abstract][Full Text] [Related]
19. Kidney size and cancer-specific survival for patients undergoing nephrectomy for pT1 clear cell renal cell carcinoma.
Jorns JJ; Thiel DD; Lohse C; Williams A; Arnold M; Cheville J; Leibovich B; Parker AS
Urology; 2012 Jul; 80(1):147-50. PubMed ID: 22748870
[TBL] [Abstract][Full Text] [Related]
20. A population-based competing-risks analysis of survival after nephrectomy for renal cell carcinoma.
Bianchi M; Gandaglia G; Trinh QD; Hansen J; Becker A; Abdollah F; Tian Z; Lughezzani G; Roghmann F; Briganti A; Montorsi F; Karakiewicz PI; Sun M
Urol Oncol; 2014 Jan; 32(1):46.e1-7. PubMed ID: 24054864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]